CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Shares withheld for taxes President & CEO gave up 19,192 shares (to pay taxes)
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Open-market sale 10% owner sold 148,700 shares at $8.11 ($1,205,660)
- 4 Open-market sale 10% owner sold 164,488 shares at an average $8.07 ($1,327,684)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 13,000 shares at $7.35 ($95,550)
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- CT ORDER Other Confidential Order
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 18 of 33 · 652 filings